OptimizeRx/$OPRX
1D1W1MYTD1Y5YMAX
About OptimizeRx
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
- Ticker
- $OPRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 133
- Headquarters
- Waltham, United States
- Website
- www.optimizerx.com
OptimizeRx Metrics
BasicAdvanced
$150M
32.31
$0.25
1.05
-
Price and volume
Market cap
$150M
Beta
1.05
52-week high
$22.25
52-week low
$4.54
Average daily volume
234K
Financial strength
Current ratio
5.576
Quick ratio
5.274
Long term debt to equity
13.734
Total debt to equity
14.861
Interest coverage (TTM)
2.41%
Profitability
EBITDA (TTM)
15.551
Gross margin (TTM)
73.22%
Net profit margin (TTM)
4.66%
Operating margin (TTM)
11.42%
Effective tax rate (TTM)
31.85%
Revenue per employee (TTM)
$740,000
Management effectiveness
Return on assets (TTM)
4.22%
Return on equity (TTM)
3.68%
Valuation
Price to earnings (TTM)
32.306
Price to revenue (TTM)
1.507
Price to book
1.14
Price to tangible book (TTM)
6.96
Price to free cash flow (TTM)
8.003
Free cash flow yield (TTM)
12.50%
Free cash flow per share (TTM)
0.993
Growth
Revenue change (TTM)
-5.82%
Earnings per share change (TTM)
-145.66%
3-year revenue growth (CAGR)
17.02%
10-year revenue growth (CAGR)
29.05%
3-year earnings per share growth (CAGR)
-33.36%
10-year earnings per share growth (CAGR)
5.96%
What the Analysts think about OptimizeRx
Analyst ratings (Buy, Hold, Sell) for OptimizeRx stock.
OptimizeRx Financial Performance
Revenues and expenses
OptimizeRx Earnings Performance
Company profitability
OptimizeRx News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.